Ifosfamide (Standard)
Based on 1 Customer Validation
Ifosfamide (Standard) is the analytical standard of Ifosfamide. This product is intended for research and analytical applications. Ifosfamide is an alkylating chemotherapeutic agent with activity against a wide range of tumors.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99.51%
- No. CAS: 3778-73-2
- Fòrmula: C₇H₁₅Cl₂N₂O₂P
- Peso molecular:261.09
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-17419
IfosfamideDNA Alkylator/Crosslinker -
HY-17420
CyclophosphamideAlkylating Agent -
HY-17394
CisplatinDNA Alkylator -
HY-B0245
BusulfanAlkylating Antineoplastic Agent -
HY-17371
OxaliplatinDNA Synthesis Inhibitor -
HY-17420A
Cyclophosphamide hydrateAlkylating Agent -
HY-17364
TemozolomideDNA Alkylator -
HY-13669
LomustineDNA Alkylator -
HY-13585
CarmustineDNA/RNA Alkylator -
HY-13733
Procarbazine HydrochlorideAlkylating Agent -
HY-17393
CarboplatinDNA Synthesis Inhibitor -
HY-17026
GemcitabineDNA Synthesis Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 3778-73-2
-
Appearance Solid
-
Peso molecular 261.09
-
Fòrmula C₇H₁₅Cl₂N₂O₂P
-
Color White to light yellow
-
SMILES
ClCCN1P(OCCC1)(NCCCl)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (644 KB)
- English - EN (644 KB)
- Français - FR (644 KB)
- Deutsch - DE (644 KB)
- Norwegian - NO (644 KB)
- Español - ES (644 KB)
- Swedish - SV (644 KB)
- Italian - IT (644 KB)
- Korean - KR (644 KB)
- Portuguese - PT (644 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Helal M. Prenatal effects of transplacental exposure to ifosfamide in rats. Biotech Histochem. 2016 Jul;91(5):357-68. [Content Brief]
[2]. Karle P, et al. Necrotic, rather than apoptotic, cell death caused by cytochrome P450-activated ifosfamide. Cancer Gene Ther. 2001 Mar;8(3):220-30. [Content Brief]
[3]. Vredenburg G, et al. Activation of the anticancer drugs cyclophosphamide and ifosfamide by cytochrome P450 BM3 mutants. Toxicol Lett. 2015 Jan 5;232(1):182-92. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Ifosfamide (Standard) Related Classifications
HY-17419R Related Classifications
Powered by Bioz